Raisa Tsvaygenbaum
Foot & Ankle Surgery · Lake Katrine, NYNPI 1629489166
Payments from drug & device makers
Across 13 payments — averaging $106.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seapearl East, Inc$854
- Stryker$416
- Smith+Nephew$33
- Kerecis Limited$27
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$21
- Organogenesis Inc.$20
- plus $20 from 1 others
What the payments were for
- Food & beverage$53539%
- Education$85461%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seapearl East, Inc | 1 | $854 |
| Stryker | 7 | $416 |
| Smith+Nephew | 1 | $33 |
| Kerecis Limited | 1 | $27 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Organogenesis Inc. | 1 | $20 |
| Convatec Inc. | 1 | $20 |
How this compares
$1,390 in reported general payments places this provider in the 40th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 14 | $10,285 |
| Ketoconazole | 58 | $700 |
| Ammonium Lactate | 22 | $457 |
| Terbinafine Hcl | 27 | $349 |
| Mupirocin | 40 | $331 |
| Clindamycin Hcl | 26 | $257 |
| Econazole Nitrate | 14 | $214 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $116 |
| Cephalexin | 19 | $102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $21 | $10,28514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 652 foot & ankle surgery providers in New York.
Other foot & ankle surgery in Lake Katrine
- James McWilliamHarrison$4.7M
- Jonathan DelandNew York$4.1M
- George Vitole Roy$2.5M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$644K
- John KennedyNew York$613K
- Michael KellerKingston$532K
- Judith BaumhauerRochester$365K
- Edward AzarBrooklyn$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.